Navigation Links
Prolifiq Announces Software for Life Sciences: Accelerates Sales, Embeds Adherence to Regulatory Compliance, Incorporates Good Promotional Practices
Date:9/14/2009

PHILADELPHIA, Sept. 14 /PRNewswire/ -- Today at the annual RAPS (Regulatory Affairs Professionals Society) conference in booth #607, Prolifiq announced software that allows Life Sciences companies to comply with an increasingly complex web of regulations governing sales communication. Prolifiq for Life Sciences--designed for medical device, pharmaceutical and biotechnology companies--is used to organize, send and track approved digital content to health care practitioners. Mobile sales representatives can customize and disseminate approved sales materials to prospective customers. An embedded rules engine monitors the communication and helps users engage in Good Promotional Practices (GPP).

Constantly evolving guidelines, regulations and laws from multiple governmental bodies make it increasingly difficult for life sciences companies to provide scientific, promotional and educational materials to health care practitioners. Since practitioners often view companies as a valuable source of information, there is strong market demand for a product that facilitates communication that complies with such standards as the FDA's Good Reprint Guidance.

How Prolifiq for Life Sciences Works

Prolifiq for Life Sciences enables mobile sales representatives to easily send approved, compliant information electronically. Imagine a medical device sales representative and a physician walking through a hospital hallway, or at the scrub sink, and the physician needs product materials immediately. Using a mobile device (including Blackberry, iPhone or Windows Mobile) the representative instantly accesses and distributes information--promotional collateral, brochures, videos, podcasts and links--right then and there. The physician receives the information instantly in his/her email inbox. By responding immediately to provider requests, the sales representative can be responsive and remain compliant. To see how Prolifiq for Life Sciences works, please visit www.Prolifiq.net/lifesciences.

"We are marrying compliance and sales, helping companies integrate compliance directly into their marketing, sales and promotional efforts while creating new efficiencies," says Jeff Gaus, CEO of Prolifiq. "We take the headache out of marketing, sales and compliance, enabling life sciences companies to focus on what they do best: developing the best products and technologies to improve life."

Good Promotional Practices Are Good for Life Sciences

Good Promotional Practices (GPP) is a term Prolifiq uses to refer to the composite set of policies and Standard Operating Procedures that ensure life sciences companies comply with applicable laws, regulations, codes of ethics and accepted industry standards related to promotional efforts.

"When Life Sciences companies can exert systematic rules-based control over their communications with providers, they have taken a significant step toward demonstrating a commitment to compliant promotional practices," said Steven Skwara, a member of the national law firm Epstein Becker Green in the Health Care and Life Sciences and Litigation Practices. "In light of the astronomical expenses that investigations or audits can generate, a life sciences company's investment in a system allowing it to comprehensively control and monitor the dissemination of scientific and promotional materials, represents a good risk management practice and helps form a first line of defense."

About Prolifiq

Prolifiq helps sales professionals use digital content in their communications with customers and prospects. Used in highly regulated environments such as Life Sciences and competitive industries such as Technology, Prolifiq's messaging solutions help sellers match approved content to their selling conversation, wrap it in branded messages and measure the effectiveness of their communications. Customers include: AtriCure, Cisco Systems, GE, The BBC, Associated Press, and Getty Images. For more information, visit www.prolifiq.net

Legal Notice: All rights reserved. Prolifiq is either a trademark or registered trademark and the Prolifiq logo is a trademark of Prolifiq Software, Inc. Product specifications are subject to change without notice.

    Media Contacts:
    Lisa MacKenzie or Kelly Stremel
    MacKenzie Marketing Group
     (503) 225-0725
    lisam@mackenzie-marketing.com
    kellys@mackenzie-marketing.com


'/>"/>
SOURCE Prolifiq
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Prolifiq Further Expands Into Medical Markets With New Hire Maureen A. Shaffer
2. CBI Announces the Agenda for Their West Coast Forum on Clinical Supply Chain Management
3. CryoLife Announces First Clinical Use of BioFoam(R)
4. Martek Announces Settlement of Patent Dispute with Capsugel France
5. Mpex Pharmaceuticals Announces Positive Phase 2b Clinical Trial Results with Aeroquin(R) (MP-376) Treatment in Cystic Fibrosis Patients
6. Esperance Pharmaceuticals Announces Initiation of Clinical Studies of its Novel Membrane-disrupting Agent, EP-100, in Patients with Cancer
7. SEQUENOM Announces Partnership With GeneWorks for Sales & Marketing of MassARRAY Systems and Applications in Australia
8. Misonix Announces New Sales Agency Agreement for Middle East, India and Pakistan
9. Simbionix USA Corporation Announces the Appointment of Mr. Paul Jensen as General Manager for its Growing eLearning and Content Business
10. Biovista Inc. Announces Positive Efficacy Results in a Pre-clinical Trial of its BVA-201 Repositioned Drug for Multiple Sclerosis
11. PharmaNet Development Group Provides Financial Update and Announces Geographic Expansion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and ... of osteosarcoma. SBT-100 is able to cross the cell membrane and bind intracellular ...
(Date:10/10/2017)... ... October 10, 2017 , ... For ... has won a US2020 STEM Mentoring Award. Representatives of the FirstHand program travelled ... Volunteer Experience from US2020. , US2020’s mission is to change the trajectory of ...
(Date:10/10/2017)... Calif. , Oct. 10, 2017 SomaGenics ... from the NIH to develop RealSeq®-SC (Single Cell), expected ... for profiling small RNAs (including microRNAs) from single cells ... Program highlights the need to accelerate development of approaches ... "New techniques for measuring levels ...
Breaking Biology Technology:
(Date:10/4/2017)...  GCE Solutions, a global clinical research organization (CRO), announces the ... on October 4, 2017. Shadow is designed to assist medical writers ... 0070 of the European Medicines Agency (EMA) in meeting the requirements ... ... ...
(Date:6/23/2017)... ITHACA, N.Y. , June 23, 2017  IBM ... in dairy research, today announced a new collaboration using ... the chances that the global milk supply is impacted ... project, Cornell University has become the newest academic institution ... Chain, a food safety initiative that includes IBM Research, ...
(Date:5/6/2017)... -- RAM Group , Singaporean based technology ... biometric authentication based on a novel  quantum-state ... perform biometric authentication. These new sensors are based on a ... Group and its partners. This sensor will have widespread ... security. Ram Group is a next generation sensor ...
Breaking Biology News(10 mins):